Between the excess of life sciences lab space on the market today and significant federal funding cuts threatening support for core research, most biotech builders aren’t in expansion mode. Which ...

Alex Wellerstein who is a historian of nuclear science has some cogent thoughts that feed into what has long since been a pet peeve of mine: the tendency for politicians, the media and scientists ...